Abacus Wealth Partners, LLC Abbott Laboratories Transaction History

Abacus Wealth Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $169,917 - $207,993	1,884 New	1,884 $207 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $18,341 - $20,436	182 Added 3.2%	5,873 $640 Million
Q1 2023 May 19, 2023	BUY	$96.86 - $114.01 $551,230 - $648,830	5,691 New	5,691 $633 Million
Q4 2022 May 31, 2023	SELL	$95.06 - $111.52 $17,491 - $20,519	-184 Reduced 3.23%	5,507 $605 Million
Q3 2022 May 31, 2023	SELL	$96.76 - $112.03 $85,632 - $99,146	-885 Reduced 13.57%	5,637 $545 Million
Q2 2022 May 31, 2023	BUY	$102.07 - $123.37 $13,269 - $16,038	130 Added 2.03%	6,522 $709 Million
Q1 2022 May 31, 2023	SELL	$114.02 - $139.04 $53,703 - $65,487	-471 Reduced 6.86%	6,392 $757 Million
Q4 2021 May 31, 2023	BUY	$115.53 - $141.46 $135,401 - $165,791	1,172 Added 20.59%	6,863 $966 Million
Q2 2021 May 31, 2023	BUY	$105.79 - $124.53 $264,157 - $310,951	2,497 Added 43.88%	8,188 $949 Million
Q1 2021 May 31, 2023	BUY	$108.84 - $128.23 $110,037 - $129,640	1,011 Added 14.04%	8,214 $984 Million
Q4 2020 May 31, 2023	BUY	$105.0 - $114.42 $158,760 - $173,003	1,512 Added 26.57%	7,203 $789 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Abacus Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Abacus Wealth Partners, LLC with notifications on news.